These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Inhibitory effects of melatonin on titanium particle-induced inflammatory bone resorption and osteoclastogenesis via suppression of NF-κB signaling. Ping Z, Wang Z, Shi J, Wang L, Guo X, Zhou W, Hu X, Wu X, Liu Y, Zhang W, Yang H, Xu Y, Gu Y, Geng D. Acta Biomater; 2017 Oct 15; 62():362-371. PubMed ID: 28867647 [Abstract] [Full Text] [Related]
4. Geraniin suppresses RANKL-induced osteoclastogenesis in vitro and ameliorates wear particle-induced osteolysis in mouse model. Xiao F, Zhai Z, Jiang C, Liu X, Li H, Qu X, Ouyang Z, Fan Q, Tang T, Qin A, Gu D. Exp Cell Res; 2015 Jan 01; 330(1):91-101. PubMed ID: 25016282 [Abstract] [Full Text] [Related]
5. Piperlongumine Inhibits Titanium Particles-Induced Osteolysis, Osteoclast Formation, and RANKL-Induced Signaling Pathways. Liu X, Diao L, Zhang Y, Yang X, Zhou J, Mao Y, Shi X, Zhao F, Liu M. Int J Mol Sci; 2022 Mar 05; 23(5):. PubMed ID: 35270008 [Abstract] [Full Text] [Related]
6. Arctigenin inhibits RANKL-induced osteoclastogenesis and hydroxyapatite resorption in vitro and prevents titanium particle-induced bone loss in vivo. Wei G, Liang T, Wei C, Nong X, Lu Q, Zhao J. J Cell Biochem; 2019 Apr 05; 120(4):5367-5376. PubMed ID: 30317692 [Abstract] [Full Text] [Related]
7. Inhibitory effects of norcantharidin on titanium particle-induced osteolysis, osteoclast activation and bone resorption via MAPK pathways. Wang J, Chen G, Yang X, Dou W, Mao Y, Zhang Y, Shi X, Xia Y, You Q, Liu M. Int Immunopharmacol; 2024 Mar 10; 129():111655. PubMed ID: 38340423 [Abstract] [Full Text] [Related]
8. Schisantherin A suppresses osteoclast formation and wear particle-induced osteolysis via modulating RANKL signaling pathways. He Y, Zhang Q, Shen Y, Chen X, Zhou F, Peng D. Biochem Biophys Res Commun; 2014 Jul 04; 449(3):344-50. PubMed ID: 24845381 [Abstract] [Full Text] [Related]
9. Genetic and pharmacological activation of Hedgehog signaling inhibits osteoclastogenesis and attenuates titanium particle-induced osteolysis partly through suppressing the JNK/c-Fos-NFATc1 cascade. Zhang L, Yang Y, Liao Z, Liu Q, Lei X, Li M, Saijilafu, Zhang Z, Hong D, Zhu M, Li B, Yang H, Chen J. Theranostics; 2020 Jul 04; 10(15):6638-6660. PubMed ID: 32550895 [Abstract] [Full Text] [Related]
10. Protein phosphatase 2A as a new target for downregulating osteoclastogenesis and alleviating titanium particle-induced bone resorption. Wang L, Guo X, Zhou W, Ding Y, Shi J, Wu X, Liu Y, Xu Y, Yang H, Geng D. Acta Biomater; 2018 Jun 04; 73():488-499. PubMed ID: 29656074 [Abstract] [Full Text] [Related]
11. Theaflavin-3,3'-digallate represses osteoclastogenesis and prevents wear debris-induced osteolysis via suppression of ERK pathway. Hu X, Ping Z, Gan M, Tao Y, Wang L, Shi J, Wu X, Zhang W, Yang H, Xu Y, Wang Z, Geng D. Acta Biomater; 2017 Jan 15; 48():479-488. PubMed ID: 27838465 [Abstract] [Full Text] [Related]
12. Rifampin suppresses osteoclastogenesis and titanium particle-induced osteolysis via modulating RANKL signaling pathways. Zhu L, Kang H, Guo CA, Fan WS, Wang YM, Deng LF, Yan ZQ. Biochem Biophys Res Commun; 2017 Feb 26; 484(1):64-70. PubMed ID: 28108285 [Abstract] [Full Text] [Related]
13. Puerarin inhibits titanium particle-induced osteolysis and RANKL-induced osteoclastogenesis via suppression of the NF-κB signaling pathway. Tang W, Xiao L, Ge G, Zhong M, Zhu J, Qin J, Feng C, Zhang W, Bai J, Zhu X, Wei M, Geng D, Wang Z. J Cell Mol Med; 2020 Oct 26; 24(20):11972-11983. PubMed ID: 32896108 [Abstract] [Full Text] [Related]
14. Sophocarpine attenuates wear particle-induced implant loosening by inhibiting osteoclastogenesis and bone resorption via suppression of the NF-κB signalling pathway in a rat model. Zhou CH, Shi ZL, Meng JH, Hu B, Zhao CC, Yang YT, Yu W, Chen ZX, Heng BC, Parkman VA, Jiang S, Zhu HX, Wu HB, Shen WL, Yan SG. Br J Pharmacol; 2018 Mar 26; 175(6):859-876. PubMed ID: 29130485 [Abstract] [Full Text] [Related]
15. Rhoifolin ameliorates titanium particle-stimulated osteolysis and attenuates osteoclastogenesis via RANKL-induced NF-κB and MAPK pathways. Liao S, Song F, Feng W, Ding X, Yao J, Song H, Liu Y, Ma S, Wang Z, Lin X, Xu J, Zhao J, Liu Q. J Cell Physiol; 2019 Aug 26; 234(10):17600-17611. PubMed ID: 30854667 [Abstract] [Full Text] [Related]
16. Vaccarin prevents titanium particle-induced osteolysis and inhibits RANKL-induced osteoclastogenesis by blocking NF-κB and MAPK signaling pathways. Liu Y, Song FM, Ma ST, Moro A, Feng WY, Liao SJ, Lin XX, Zhao JM, Wang ZY, Xu J, Zhan XL, Liu Q. J Cell Physiol; 2019 Aug 26; 234(8):13832-13842. PubMed ID: 30637734 [Abstract] [Full Text] [Related]
17. Jatrorrhizine Hydrochloride Suppresses RANKL-Induced Osteoclastogenesis and Protects against Wear Particle-Induced Osteolysis. Li H, Wang J, Sun Q, Chen G, Sun S, Ma X, Qiu H, Liu X, Xu L, Liu M. Int J Mol Sci; 2018 Nov 21; 19(11):. PubMed ID: 30469456 [Abstract] [Full Text] [Related]
19. Bulleyaconitine A prevents Ti particle-induced osteolysis via suppressing NF-κB signal pathway during osteoclastogenesis and osteoblastogenesis. Zhang L, Feng M, Li Z, Zhu M, Fan Y, Chu B, Yuan C, Chen L, Lv H, Hong Z, Hong D. J Cell Physiol; 2018 Sep 21; 233(9):7067-7079. PubMed ID: 29388671 [Abstract] [Full Text] [Related]
20. The prevention of titanium-particle-induced osteolysis by OA-14 through the suppression of the p38 signaling pathway and inhibition of osteoclastogenesis. Tian B, Jiang T, Shao Z, Zhai Z, Li H, Fan Q, Liu X, Ouyang Z, Tang T, Jiang Q, Zheng M, Dai K, Qin A, Yu Y, Zhu Z. Biomaterials; 2014 Oct 21; 35(32):8937-50. PubMed ID: 25086794 [Abstract] [Full Text] [Related] Page: [Next] [New Search]